SCHEMBL7987470

SCHEMBL7987470

CCc1nc(=O)c2c(ncn2Cc2ccc(OC)c(OC)c2)[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.41
ROCK1 Q13464 1/20 0.41
MAPK10 P53779 1/20 0.40
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
P2RX7 Q99572 4/20 0.39
KMT2A Q03164 1/20 0.39
CSF1R P07333 2/20 0.39
ALDH1A1 P00352 1/20 0.38
QPCT Q16769 2/20 0.38
QPCTL Q9NXS2 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
YTHDC1 Q96MU7 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985247 0.88 HSP90AA1 (0.45) KMT2A
SCHEMBL7984516 0.84 TP53 (0.53) ROCK2ROCK1YTHDC1
SCHEMBL7987464 0.83 HPGD (0.41) ROCK2ROCK1TSHRMAPK1KMT2A
SCHEMBL7985654 0.82 CNOT7 (0.42) ALDH1A1CYP1A2
SCHEMBL7987439 0.82 CNOT7 (0.43) TSHRMAPK1KMT2AALDH1A1CYP1A2
SCHEMBL7988132 0.81 CNOT7 (0.44) MAPK1ALDH1A1
SCHEMBL7984530 0.81 HPGD (0.46) P2RX7KMT2AALDH1A1
SCHEMBL7975254 0.80 CNOT7 (0.55) KMT2AALDH1A1
SCHEMBL7984380 0.80 CYP11B1 (0.40) TSHRP2RX7ALDH1A1
SCHEMBL7974262 0.80 ALDH1A1 (0.45) TSHRKMT2AALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed